FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Miltiades Eliopoulos

Research Profile

Procedures

Chemicals & Drugs

Physiology

Living Beings

Disorders

Co-author Network

Publications

TOP 3
Christian Joukhadar; Satish Pillai; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.
Jessica R Galloway-Peña; Sreedhar R Nallapareddy; Cesar A Arias; George Miltiades Eliopoulos; Barbara E Murray
Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States.
Satish K Pillai; Christine Wennersten; Lata Venkataraman; George Miltiades Eliopoulos; Robert C Moellering; Adolf W Karchmer
Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Miltiades Eliopoulos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Christian Joukhadar; Satish Pillai; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2010;54(2):773-7.
2009: Jessica R Galloway-Peña; Sreedhar R Nallapareddy; Cesar A Arias; George Miltiades Eliopoulos; Barbara E Murray
Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States.
The Journal of infectious diseases 2009;200(10):1566-73.
2009: Satish K Pillai; Christine Wennersten; Lata Venkataraman; George Miltiades Eliopoulos; Robert C Moellering; Adolf W Karchmer
Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(8):1169-74.
2009: George Miltiades Eliopoulos
Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
The Journal of infection 2009;59 Suppl 1():S17-24.
2009: Anton Y Peleg; Sebastian Jara; Divya Monga; George Miltiades Eliopoulos; Robert C Moellering; Eleftherios Mylonakis
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.
Antimicrobial agents and chemotherapy 2009;53(6):2605-9.
2009: A Y Peleg; Y Tilahun; M J Fiandaca; Erika M C D'Agata; Lata Venkataraman; Robert C Moellering; George Miltiades Eliopoulos
Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosa.
Journal of clinical microbiology 2009;47(3):830-2.
2009: Anton Y Peleg; Divya Monga; Satish Pillai; Eleftherios Mylonakis; Robert C Moellering; George Miltiades Eliopoulos
Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.
The Journal of infectious diseases 2009;199(4):532-6.
2008: Anton Y Peleg; Emmanouil Tampakakis; Beth Burgwyn Fuchs; George Miltiades Eliopoulos; Robert C Moellering; Eleftherios Mylonakis
Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(38):14585-90.
2008: Zukile Gqada; Ben Marais; Elizabeth Wasserman; Colleen Bamford; Heidi Orth; George Sakoulas; Warren E Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George Miltiades Eliopoulos
Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Journal of clinical microbiology 2008;46(7):2471; author reply 2471-2.
2008: George Sakoulas; Warren E Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George Miltiades Eliopoulos
Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Journal of clinical microbiology 2008;46(1):220-4.
2007: Athanassios Tsakris; Satish K Pillai; Howard S Gold; Claudie Thauvin-Eliopoulos; Lata Venkataraman; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2007;60(3):649-51.
2007: Satish K Pillai; Howard S Gold; George Sakoulas; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Antimicrobial agents and chemotherapy 2007;51(6):2223-5.
2006: Heungsup Sung; Hee Bong Shin; Mi-Na Kim; Kyungwon Lee; Eui-Chong Kim; Wonkeun Song; Seok Hoon Jeong; Wee Gyo Lee; Yeon-Joon Park; George Miltiades Eliopoulos
Vancomycin-tolerant Streptococcus pneumoniae in Korea.
Journal of clinical microbiology 2006;44(10):3524-8.
2006: George Miltiades Eliopoulos
Enterococci: on the back burner but still simmering.
Current infectious disease reports 2006;8(5):333-6.
2006: George Sakoulas; Jeff Alder; Claudie Thauvin-Eliopoulos; Robert C Moellering; George Miltiades Eliopoulos
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
Antimicrobial agents and chemotherapy 2006;50(4):1581-5.
2006: George Sakoulas; Howard S Gold; Robert A Cohen; Lata Venkataraman; Robert C Moellering; George Miltiades Eliopoulos
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
The Journal of antimicrobial chemotherapy 2006;57(4):699-704.
2006: George Sakoulas; Robert C Moellering; George Miltiades Eliopoulos
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42 Suppl 1():S40-50.
2005: George Miltiades Eliopoulos
Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(12):826-31.
2005: George Miltiades Eliopoulos; Mary Jane Ferraro; Christine Wennersten; Robert C Moellering
In vitro activity of an oral streptogramin antimicrobial, XRP2868, against gram-positive bacteria.
Antimicrobial agents and chemotherapy 2005;49(7):3034-9.
2005: George Sakoulas; George Miltiades Eliopoulos; Vance G Fowler; Robert C Moellering; Richard novick; Natalie Lucindo; Michael Yeaman; Arnold S Bayer
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.
Antimicrobial agents and chemotherapy 2005;49(7):2687-92.
2005: Roger G Finch; George Miltiades Eliopoulos
Safety and efficacy of glycopeptide antibiotics.
The Journal of antimicrobial chemotherapy 2005;55 Suppl 2():ii5-13.
2004: Venkata G Meka; Howard S Gold; Amy Cooke; Lata Venkataraman; George Miltiades Eliopoulos; Robert C Moellering; Stephen G Jenkins
Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2004;54(4):818-20.
2004: Vance G Fowler; George Sakoulas; Lauren M McIntyre; Venkata G Meka; Robert D Arbeit; Christopher H Cabell; Martin E Stryjewski; George Miltiades Eliopoulos; L Barth Reller; G Ralph Corey; Tiffanny Jones; Natalie Lucindo; Michael Yeaman; Arnold S Bayer
Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.
The Journal of infectious diseases 2004;190(6):1140-9.
2004: Satish K Pillai; George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Barbara E Murray; Roger T Inouye
Effects of glucose on fsr-mediated biofilm formation in Enterococcus faecalis.
The Journal of infectious diseases 2004;190(5):967-70.
2004: Venkata G Meka; Satish K Pillai; George Sakoulas; Christine Wennersten; Lata Venkataraman; Paola C DeGirolami; George Miltiades Eliopoulos; Robert C Moellering; Howard S Gold
Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
The Journal of infectious diseases 2004;190(2):311-7.
2004: Pamela A Moise-Broder; George Sakoulas; George Miltiades Eliopoulos; Jerome J Schentag; Alan Forrest; Robert C Moellering
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(12):1700-5.
2004: George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George Miltiades Eliopoulos
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Journal of clinical microbiology 2004;42(6):2398-402.
2004: George Miltiades Eliopoulos
Quinolone resistance mechanisms in pneumococci.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38 Suppl 4():S350-6.
2004: George Miltiades Eliopoulos
Current and new antimicrobial agents.
American heart journal 2004;147(4):587-92.
2003: Richard E Person; Feng-Qian Li; Zhijun Duan; Kathleen F Benson; Jeremy Wechsler; Helen A Papadaki; George Miltiades Eliopoulos; Christina Kaufman; Salvatore J Bertolone; Betty Nakamoto; Thalia Papayannopoulou; H Leighton Grimes; Marshall Horwitz
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.
Nature genetics 2003;34(3):308-12.
2003: George Sakoulas; George Miltiades Eliopoulos; Jeff Alder; Claudie Thauvin Eliopoulos
Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2003;47(5):1714-8.
2003: George Sakoulas; Howard S Gold; Lata Venkataraman; Robert C Moellering; Mary Jane Ferraro; George Miltiades Eliopoulos
Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility.
The Journal of antimicrobial chemotherapy 2003;51(4):1039-41.
2003: George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Richard novick; Lata Venkataraman; Christine Wennersten; Paola C DeGirolami; Mitchell J Schwaber; Howard S Gold
Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?
The Journal of infectious diseases 2003;187(6):929-38.
2003: George Miltiades Eliopoulos
Quinupristin-dalfopristin and linezolid: evidence and opinion.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(4):473-81.
2002: Satish K Pillai; George Sakoulas; Christine Wennersten; George Miltiades Eliopoulos; Robert C Moellering; Mary Jane Ferraro; Howard S Gold
Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
The Journal of infectious diseases 2002;186(11):1603-7.
2002: Yehuda Carmeli; George Miltiades Eliopoulos; Essy Mozaffari; Matthew H Samore
Health and economic outcomes of vancomycin-resistant enterococci.
Archives of internal medicine 2002;162(19):2223-8.
2002: George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
In vitro activity of the new oxazolidinone AZD2563 against Enterococci.
Antimicrobial agents and chemotherapy 2002;46(10):3273-5.
2002: Yehuda Carmeli; George Miltiades Eliopoulos; Matthew H Samore
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
Emerging infectious diseases 2002;8(8):802-7.
2002: Satish K Pillai; George Sakoulas; Howard S Gold; Christine Wennersten; George Miltiades Eliopoulos; Robert C Moellering; Roger T Inouye
Prevalence of the fsr locus in Enterococcus faecalis infections.
Journal of clinical microbiology 2002;40(7):2651-2.
2002: George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Christine Wennersten; Lata Venkataraman; Richard novick; Howard S Gold
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
Antimicrobial agents and chemotherapy 2002;46(5):1492-502.
2002: George Miltiades Eliopoulos; Christine Wennersten
Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci.
Antimicrobial agents and chemotherapy 2002;46(5):1319-24.
2002: Lindsey R Baden; I A Critchley; D F Sahm; W So; M Gedde; S Porter; Robert C Moellering; George Miltiades Eliopoulos
Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin.
Journal of clinical microbiology 2002;40(4):1160-3.
2001: Lindsey R Baden; G Horowitz; H Jacoby; George Miltiades Eliopoulos
Quinolones and false-positive urine screening for opiates by immunoassay technology.
JAMA : the journal of the American Medical Association 2001;286(24):3115-9.
2001: Lindsey R Baden; W Thiemke; A Skolnik; R Chambers; J Strymish; Howard S Gold; Robert C Moellering; George Miltiades Eliopoulos
Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance".
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(10):1654-60.
2001: George Sakoulas; Howard S Gold; Lata Venkataraman; Paola C DeGirolami; George Miltiades Eliopoulos; Q Qian
Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
Journal of clinical microbiology 2001;39(11):3946-51.
2001: Keith Steven Kaye; Sara E Cosgrove; Anthony D Harris; George Miltiades Eliopoulos; Yehuda Carmeli
Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
Antimicrobial agents and chemotherapy 2001;45(9):2628-30.
2001: S Tsiodras; Howard S Gold; George Sakoulas; George Miltiades Eliopoulos; Christine Wennersten; Lata Venkataraman; Robert C Moellering; Mary Jane Ferraro
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
Lancet 2001;358(9277):207-8.
2001: C Torres-Viera; S Tsiodras; Howard S Gold; Eoin P G Coakley; Christine Wennersten; George Miltiades Eliopoulos; Robert C Moellering; Roger T Inouye
Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer.
Antimicrobial agents and chemotherapy 2001;45(3):973-5.
2001: D H Batts; B S Lavin; George Miltiades Eliopoulos
Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
Current clinical topics in infectious diseases 2001;21():227-51.
2001: Yehuda Carmeli; J Castro; George Miltiades Eliopoulos; Matthew H Samore
Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam.
Antimicrobial agents and chemotherapy 2001;45(1):275-9.
2001: H W Boucher; Claudie Thauvin-Eliopoulos; D Loebenberg; George Miltiades Eliopoulos
In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.
Antimicrobial agents and chemotherapy 2001;45(1):208-11.
2000: S Tsiodras; Howard S Gold; Eoin P G Coakley; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Diversity of domain V of 23S rRNA gene sequence in different Enterococcus species.
Journal of clinical microbiology 2000;38(11):3991-3.
2000: A M Queenan; C Torres-Viera; Howard S Gold; Yehuda Carmeli; George Miltiades Eliopoulos; Robert C Moellering; J P Quinn; Janet Hindler; A A Medeiros; Karen Bush
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains.
Antimicrobial agents and chemotherapy 2000;44(11):3035-9.
2000: M Souli; Claudie Thauvin-Eliopoulos; George Miltiades Eliopoulos
In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.
Antimicrobial agents and chemotherapy 2000;44(10):2733-9.
2000: H W Boucher; Christine Wennersten; George Miltiades Eliopoulos
In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria.
Antimicrobial agents and chemotherapy 2000;44(8):2225-9.
2000: C Torres-Viera; Claudie Thauvin-Eliopoulos; M Souli; Paola C DeGirolami; MG Farris; Christine Wennersten; R D Sofia; George Miltiades Eliopoulos
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
Antimicrobial agents and chemotherapy 2000;44(6):1720-4.
1999: T Schülin; Claudie Thauvin-Eliopoulos; Robert C Moellering; George Miltiades Eliopoulos
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
Antimicrobial agents and chemotherapy 1999;43(12):2873-6.
1999: Belinda Ostrowsky; N C Clark; Claudie Thauvin-Eliopoulos; Lata Venkataraman; Matthew H Samore; Fred C Tenover; George Miltiades Eliopoulos; Robert C Moellering; Howard S Gold
A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology.
The Journal of infectious diseases 1999;180(4):1177-85.
1999: Erika M C D'Agata; Lata Venkataraman; Paola C DeGirolami; P Burke; George Miltiades Eliopoulos; Adolf W Karchmer; Matthew H Samore
Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection.
Critical care medicine 1999;27(6):1090-5.
1999: Yehuda Carmeli; N Troillet; George Miltiades Eliopoulos; Matthew H Samore
Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents.
Antimicrobial agents and chemotherapy 1999;43(6):1379-82.
1999: George Miltiades Eliopoulos
Activity of newer fluoroquinolones in vitro against gram-positive bacteria.
Drugs 1999;58 Suppl 2():23-8.
1998: T Schülin; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
The Journal of antimicrobial chemotherapy 1998;42(3):297-301.
1998: T Schülin; Christine Wennersten; Mary Jane Ferraro; Robert C Moellering; George Miltiades Eliopoulos
Susceptibilities of Legionella spp. to newer antimicrobials in vitro.
Antimicrobial agents and chemotherapy 1998;42(6):1520-3.
1998: George Miltiades Eliopoulos; Christine Wennersten; Howard S Gold; T Schülin; M Souli; MG Farris; S Cerwinka; HL Nadler; M Dowzicky; George H Talbot; Robert C Moellering
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin.
Antimicrobial agents and chemotherapy 1998;42(5):1088-92.
1998: M Souli; Christine Wennersten; George Miltiades Eliopoulos
In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens.
International journal of antimicrobial agents 1998;10(1):23-30.
1997: George Miltiades Eliopoulos
Vancomycin-resistant enterococci. Mechanism and clinical relevance.
Infectious disease clinics of North America 1997;11(4):851-65.
1997: F Caron; Howard S Gold; Christine Wennersten; MG Farris; Robert C Moellering; George Miltiades Eliopoulos
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.
Antimicrobial agents and chemotherapy 1997;41(12):2749-53.
1997: George Miltiades Eliopoulos; Christine Wennersten
In vitro activity of trimethoprim alone compared with trimethoprim-sulfamethoxazole and other antimicrobials against bacterial species associated with upper respiratory tract infections.
Diagnostic microbiology and infectious disease 1997;29(1):33-8.
1997: T Schülin; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
Antimicrobial agents and chemotherapy 1997;41(5):1196-202.
1997: Claudie Thauvin-Eliopoulos; M F Tripodi; Robert C Moellering; George Miltiades Eliopoulos
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.
Antimicrobial agents and chemotherapy 1997;41(5):1053-7.
1996: George Miltiades Eliopoulos; Christine Wennersten; Howard S Gold; Robert C Moellering
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
Antimicrobial agents and chemotherapy 1996;40(7):1745-7.
1996: George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
Diagnostic microbiology and infectious disease 1996;25(1):35-41.
1996: George Miltiades Eliopoulos
Antibiotic resistance in Enterococcus species: an update.
Current clinical topics in infectious diseases 1996;16():21-51.
1995: Emilia Cercenado; S Unal; C T Eliopoulos; Lorry Rubin; H D Isenberg; Robert C Moellering; George Miltiades Eliopoulos
Characterization of vancomycin resistance in Enterococcus durans.
The Journal of antimicrobial chemotherapy 1995;36(5):821-5.
1995: George Miltiades Eliopoulos; C B Wennersten; G Cole; R C Moellering
In vitro activity of WY-49605, a penem antimicrobial.
International journal of antimicrobial agents 1995;5(4):251-7.
1995: G Malanoski; L Collins; C T Eliopoulos; Robert C Moellering; George Miltiades Eliopoulos
Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria.
Antimicrobial agents and chemotherapy 1995;39(4):990-5.
1995: George Miltiades Eliopoulos; Christine Wennersten; G Cole; D Chu; D Pizzuti; Robert C Moellering
In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent.
Antimicrobial agents and chemotherapy 1995;39(4):850-3.
1995: George Miltiades Eliopoulos
In vitro activity of fluoroquinolones against gram-positive bacteria.
Drugs 1995;49 Suppl 2():48-57.
1994: George Miltiades Eliopoulos; Christine Wennersten; G Cole; Robert C Moellering
In vitro activities of two glycylcyclines against gram-positive bacteria.
Antimicrobial agents and chemotherapy 1994;38(3):534-41.
1994: ANGELOS PEFANIS; C Thauvin-Eliopoulos; J Holden; George Miltiades Eliopoulos; M J Ferraro; Robert C Moellering
Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses.
Antimicrobial agents and chemotherapy 1994;38(2):252-5.
1994: L A Collins; Christine Wennersten; M J Ferraro; Robert C Moellering; George Miltiades Eliopoulos
Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.
Antimicrobial agents and chemotherapy 1994;38(1):144-6.
1993: G J Malanoski; L Collins; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria.
Antimicrobial agents and chemotherapy 1993;37(9):2009-16.
1993: ANGELOS PEFANIS; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; Robert C Moellering
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis.
The Journal of antimicrobial chemotherapy 1993;32(2):307-12.
1993: Howard S Gold; S Unal; Emilia Cercenado; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.
Antimicrobial agents and chemotherapy 1993;37(8):1604-9.
1993: George Miltiades Eliopoulos
Increasing problems in the therapy of enterococcal infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(6):409-12.
1993: L A Collins; George Miltiades Eliopoulos; Christine Wennersten; M J Ferraro; Robert C Moellering
In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
Antimicrobial agents and chemotherapy 1993;37(6):1364-6.
1993: George Miltiades Eliopoulos
Aminoglycoside resistant enterococcal endocarditis.
Infectious disease clinics of North America 1993;7(1):117-33.
1993: L A Collins; G J Malanoski; George Miltiades Eliopoulos; Christine Wennersten; M J Ferraro; Robert C Moellering
In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.
Antimicrobial agents and chemotherapy 1993;37(3):598-601.
1993: ANGELOS PEFANIS; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; Robert C Moellering
Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Antimicrobial agents and chemotherapy 1993;37(3):507-11.
1993: George Miltiades Eliopoulos; K Klimm; C T Eliopoulos; M J Ferraro; Robert C Moellering
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.
Antimicrobial agents and chemotherapy 1993;37(2):366-70.
1993: G J Malanoski; George Miltiades Eliopoulos; M J Ferraro; Robert C Moellering
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(2):131-3.
1993: W W Hoover; E H Gerlach; D J Hoban; George Miltiades Eliopoulos; Michael A Pfaller; Ronald Jones
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
Diagnostic microbiology and infectious disease 1993;16(2):111-8.
1992: Emilia Cercenado; George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.
Antimicrobial agents and chemotherapy 1992;36(11):2526-8.
1992: Emilia Cercenado; George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci.
Antimicrobial agents and chemotherapy 1992;36(10):2201-3.
1992: M C Ramos; M L Grayson; George Miltiades Eliopoulos; A S Bayer
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Antimicrobial agents and chemotherapy 1992;36(9):1864-9.
1992: George Miltiades Eliopoulos; C Thauvin-Eliopoulos; Robert C Moellering
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(1):58-62.
1992: G J Malanoski; R Parker; George Miltiades Eliopoulos
Antimicrobial susceptibilities of a Corynebacterium CDC group I1 strain isolated from a patient with endocarditis.
Antimicrobial agents and chemotherapy 1992;36(6):1329-31.
1992: Louis B Rice; C T Eliopoulos; J D Yao; George Miltiades Eliopoulos; Robert C Moellering
In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model.
Diagnostic microbiology and infectious disease 1992;15(2):173-6.
1992: T L Hodges; S Zighelboim-Daum; George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.
Antimicrobial agents and chemotherapy 1992;36(1):121-5.
1991: M L Grayson; George Miltiades Eliopoulos; Christine Wennersten; Kathryn L Ruoff; P C De Girolami; M J Ferraro; Robert C Moellering
Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution.
Antimicrobial agents and chemotherapy 1991;35(11):2180-4.
1991: M L Grayson; George Miltiades Eliopoulos; Christine Wennersten; Kathryn L Ruoff; K Klimm; F L Sapico; A S Bayer; Robert C Moellering
Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance.
Antimicrobial agents and chemotherapy 1991;35(7):1408-12.
1991: Louis B Rice; J D Yao; K Klimm; George Miltiades Eliopoulos; Robert C Moellering
Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.
Antimicrobial agents and chemotherapy 1991;35(6):1243-4.
1991: Barbara E Murray; Kavindra V Singh; S M Markowitz; H A Lopardo; Jan Patterson; Marcus Zervos; E Rubeglio; George Miltiades Eliopoulos; L B Rice; F W Goldstein
Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states.
The Journal of infectious diseases 1991;163(4):780-5.
1991: Louis B Rice; George Miltiades Eliopoulos; Christine Wennersten; Donald A Goldmann; George Jacoby; Robert C Moellering
Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis.
Antimicrobial agents and chemotherapy 1991;35(2):272-6.
1991: Louis B Rice; S B Calderwood; George Miltiades Eliopoulos; B F Farber; A W Karchmer
Enterococcal endocarditis: a comparison of prosthetic and native valve disease.
Reviews of infectious diseases 1991;13(1):1-7.
1990: E Rhinehart; N E Smith; C Wennersten; E Gorss; J Freeman; George Miltiades Eliopoulos; R C Moellering; Donald A Goldmann
Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward.
The New England journal of medicine 1990;323(26):1814-8.
1990: Louis B Rice; S H Willey; Genovefa A Papanicolaou; AA Medeiros; George Miltiades Eliopoulos; Robert C Moellering; George Jacoby
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.
Antimicrobial agents and chemotherapy 1990;34(11):2193-9.
1990: T L Hodges; George Miltiades Eliopoulos; K Klimm; Robert C Moellering
In vitro activity of BAY v 3522, a new cephalosporin for oral administration.
Antimicrobial agents and chemotherapy 1990;34(9):1849-54.
1990: M L Grayson; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; J D Yao; D V DeAngelis; L Walton; J L Woolley; Robert C Moellering
Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.
Antimicrobial agents and chemotherapy 1990;34(9):1792-4.
1990: M L Grayson; George Miltiades Eliopoulos
Antimicrobial resistance in the intensive care unit.
Seminars in respiratory infections 1990;5(3):204-14.
1990: George Miltiades Eliopoulos; K Klimm; M L Grayson
In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent.
Diagnostic microbiology and infectious disease 1990;13(4):345-8.
1990: George Miltiades Eliopoulos; K Klimm; Louis B Rice; M J Ferraro; Robert C Moellering
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.
Antimicrobial agents and chemotherapy 1990;34(6):1154-9.
1990: C Thauvin-Eliopoulos; Louis B Rice; George Miltiades Eliopoulos; Robert C Moellering
Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Antimicrobial agents and chemotherapy 1990;34(5):728-32.
1990: J D Yao; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; Robert C Moellering
Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
Antimicrobial agents and chemotherapy 1990;34(5):827-30.
1990: George Miltiades Eliopoulos; C T Eliopoulos
Therapy of enterococcal infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(2):118-26.
1989: George Miltiades Eliopoulos; C T Eliopoulos
Ciprofloxacin in combination with other antimicrobials.
The American journal of medicine 1989;87(5A):17S-22S.
1989: George Miltiades Eliopoulos; K Klimm; M J Ferraro; George Jacoby; Robert C Moellering
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).
Diagnostic microbiology and infectious disease 1989;12(6):481-8.
1989: M L Grayson; George Miltiades Eliopoulos; M J Ferraro; Robert C Moellering
Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(10):888-9.
1989: Robert C Moellering; George Miltiades Eliopoulos; D E Sentochnik
The carbapenems: new broad spectrum beta-lactam antibiotics.
The Journal of antimicrobial chemotherapy 1989;24 Suppl A():1-7.
1989: George Miltiades Eliopoulos
Synergism and antagonism.
Infectious disease clinics of North America 1989;3(3):399-406.
1989: S H Willey; R G Hindes; George Miltiades Eliopoulos; Robert C Moellering
Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess.
Surgery, gynecology & obstetrics 1989;169(3):199-202.
1989: D E Sentochnik; George Miltiades Eliopoulos; M J Ferraro; Robert C Moellering
Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent.
Antimicrobial agents and chemotherapy 1989;33(8):1232-6.
1989: R G Hindes; S H Willey; George Miltiades Eliopoulos; Louis B Rice; C T Eliopoulos; B E Murray; Robert C Moellering
Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
Antimicrobial agents and chemotherapy 1989;33(7):1019-22.
1989: George Miltiades Eliopoulos; K Klimm; M J Ferraro; Robert C Moellering
In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(7):624-6.
1989: J D Yao; George Miltiades Eliopoulos; Robert C Moellering
In vitro activity of SK&F 104662, a new glycopeptide antibiotic.
Antimicrobial agents and chemotherapy 1989;33(6):965-7.
1989: C A Clyne; George Miltiades Eliopoulos
Fever and urticaria in acute giardiasis.
Archives of internal medicine 1989;149(4):939-40.
1989: Louis B Rice; George Miltiades Eliopoulos; Robert C Moellering
In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.
Antimicrobial agents and chemotherapy 1989;33(4):470-3.
1989: George Miltiades Eliopoulos; E Reiszner; S Willey; W J Novick; R C Moellering
Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against Enterococcus faecalis.
Diagnostic microbiology and infectious disease 1989;12(2):149-56.
1989: L B Rice; George Miltiades Eliopoulos
Imipenem and aztreonam: current role in antimicrobial therapy.
Current clinical topics in infectious diseases 1989;10():109-39.
1988: George Miltiades Eliopoulos; Christine Wennersten; S Zighelboim-Daum; E Reiszner; Donald A Goldmann; Robert C Moellering
High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.
Antimicrobial agents and chemotherapy 1988;32(10):1528-32.
1988: J S Daly; George Miltiades Eliopoulos; S Willey; Robert C Moellering
Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound.
Antimicrobial agents and chemotherapy 1988;32(9):1341-6.
1988: George Miltiades Eliopoulos
Induction of beta-lactamases.
The Journal of antimicrobial chemotherapy 1988;22 Suppl A():37-44.
1988: J S Daly; George Miltiades Eliopoulos; E Reiszner; Robert C Moellering
Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds.
The Journal of antimicrobial chemotherapy 1988;21(6):721-30.
1988: George Miltiades Eliopoulos; C T Eliopoulos
Antibiotic combinations: should they be tested?
Clinical microbiology reviews 1988;1(2):139-56.
1988: P G Spitzer; George Miltiades Eliopoulos; A W Karchmer; Robert C Moellering
Synergistic activity between vancomycin or teicoplanin and gentamicin or tobramycin against pathogenic diphtheroids.
Antimicrobial agents and chemotherapy 1988;32(4):434-7.
1988: George Miltiades Eliopoulos
New quinolones: pharmacology, pharmacokinetics, and dosing in patients with renal insufficiency.
Reviews of infectious diseases 1988;10 Suppl 1():S102-5.
1987: J D Allan; George Miltiades Eliopoulos; E Reiszner; Robert C Moellering
In vitro activities of ICI 194008 and ICI 193428, two new cephem antimicrobial agents.
Antimicrobial agents and chemotherapy 1987;31(12):1997-2001.
1987: M E Sherman; M Albrecht; Paola C DeGirolami; S A Kirkley; B Wolf; George Miltiades Eliopoulos; R J Rohrer; A P Monaco
An unusual case of splenic abscess and sepsis in an immunocompromised host.
American journal of clinical pathology 1987;88(5):659-62.
1987: George Miltiades Eliopoulos; E Reiszner; M J Ferraro; Robert C Moellering
Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
The Journal of antimicrobial chemotherapy 1987;20(5):671-5.
1987: S A Hoffmann; George Miltiades Eliopoulos
Antibiotic resistance in the hospital setting: extent of the problem and possible solutions.
Hospital formulary 1987;22(10):852-7, 860-3.
1987: George Miltiades Eliopoulos; Christine Wennersten; E Reiszner; Robert C Moellering
Comparative in vitro activity of CGP 31608, a new penem antibiotic.
Antimicrobial agents and chemotherapy 1987;31(8):1188-93.
1987: P G Spitzer; D Tarsy; George Miltiades Eliopoulos
Acute transverse myelitis during disseminated cytomegalovirus infection in a renal transplant recipient.
Transplantation 1987;44(1):151-3.
1987: George Miltiades Eliopoulos; E Reiszner; R C Moellering
In vitro evaluation of the new paulomycin antibiotic paldimycin.
European journal of clinical microbiology 1987;6(3):306-8.
1987: George Miltiades Eliopoulos; E Reiszner; Christine Wennersten; Robert C Moellering
In vitro activity of BMY-28100, a new oral cephalosporin.
Antimicrobial agents and chemotherapy 1987;31(4):653-6.
1987: P G Spitzer; George Miltiades Eliopoulos; A W Karchmer; Robert C Moellering
Comparative in vitro activity of the new cyclic lipopeptide LY146032 against Corynebacterium species.
European journal of clinical microbiology 1987;6(2):183-5.
1987: C Thauvin; George Miltiades Eliopoulos; S Willey; C Wennersten; R C Moellering
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
Antimicrobial agents and chemotherapy 1987;31(2):139-43.
1986: George Miltiades Eliopoulos; E Reiszner; G M Caputo; R C Moellering
In vitro activity of CI-934, a new quinolone antimicrobial, against gram-positive bacteria.
Diagnostic microbiology and infectious disease 1986;5(4):341-4.
1986: George Miltiades Eliopoulos; S Willey; E Reiszner; P G Spitzer; G Caputo; R C Moellering
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.
Antimicrobial agents and chemotherapy 1986;30(4):532-5.
1986: R C Moellering; George Miltiades Eliopoulos; J D Allan
Beta-lactam/aminoglycoside combinations: interactions and their mechanisms.
The American journal of medicine 1986;80(5C):30-4.
1986: J D Allan; George Miltiades Eliopoulos; R C Moellering
The expanding spectrum of beta-lactam antibiotics.
Advances in internal medicine 1986;31():119-46.
1985: George Miltiades Eliopoulos; A E Moellering; E Reiszner; R C Moellering
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.
Antimicrobial agents and chemotherapy 1985;28(4):514-20.
1985: C Thauvin; George Miltiades Eliopoulos; C Wennersten; R C Moellering
Antagonistic effect of penicillin-amikacin combinations against enterococci.
Antimicrobial agents and chemotherapy 1985;28(1):78-83.
1985: J D Allan; George Miltiades Eliopoulos; M J Ferraro; R C Moellering
Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.
Antimicrobial agents and chemotherapy 1985;27(5):782-90.
1985: George Miltiades Eliopoulos; C Thauvin; B Gerson; R C Moellering
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.
Antimicrobial agents and chemotherapy 1985;27(3):357-62.
1985: George Miltiades Eliopoulos; E Reiszner; R C Moellering
In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.
Antimicrobial agents and chemotherapy 1985;27(1):28-32.
1984: R C Moellering; George Miltiades Eliopoulos
Activity of cefotaxime against enterococci.
Diagnostic microbiology and infectious disease 1984;2(3 Suppl):85S-90S.
1984: P G Spitzer; George Miltiades Eliopoulos
Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis.
Annals of internal medicine 1984;100(4):533-4.
1984: George Miltiades Eliopoulos; A Gardella; P DeGirolami; R C Moellering
In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates.
Antimicrobial agents and chemotherapy 1984;25(4):401-4.
1984: George Miltiades Eliopoulos; A Gardella; R C Moellering
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
Antimicrobial agents and chemotherapy 1984;25(3):331-5.
1984: George Miltiades Eliopoulos; B F Farber; B E Murray; C Wennersten; R C Moellering
Ribosomal resistance of clinical enterococcal to streptomycin isolates.
Antimicrobial agents and chemotherapy 1984;25(3):398-9.
1983: B F Farber; George Miltiades Eliopoulos; J I Ward; K Ruoff; R C Moellering
Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococci.
Antimicrobial agents and chemotherapy 1983;24(6):871-5.
1983: B F Farber; George Miltiades Eliopoulos; J I Ward; K L Ruoff; V Syriopoulou; R C Moellering
Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns.
Antimicrobial agents and chemotherapy 1983;24(5):702-5.
1982: R C Moellering; S Willey; George Miltiades Eliopoulos
Synergism and antagonism of ceftizoxime and other new cephalosporins.
The Journal of antimicrobial chemotherapy 1982;10 Suppl C():69-79.
1982: George Miltiades Eliopoulos; R C Moellering
Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
Annals of internal medicine 1982;97(5):755-60.
1982: George Miltiades Eliopoulos; C Wennersten; R C Moellering
Resistance to beta-lactam antibiotics in Streptococcus faecium.
Antimicrobial agents and chemotherapy 1982;22(2):295-301.
1982: George Miltiades Eliopoulos; R C Moellering
Antibiotic synergism and antimicrobial combinations in clinical infections.
Reviews of infectious diseases 1982;4(2):282-93.
1982: George Miltiades Eliopoulos; A Gardella; R C Moellering
In-vitro activity of Sch 29482 in comparison with other oral antibiotics.
The Journal of antimicrobial chemotherapy 1982;9 Suppl C():143-52.
1982: George Miltiades Eliopoulos; R C Moellering
Principles of antibiotic therapy.
The Medical clinics of North America 1982;66(1):3-15.
1981: George Miltiades Eliopoulos; R C Moellering
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.
Antimicrobial agents and chemotherapy 1981;19(5):789-93.